Cargando…

Laminin α2 Chain-Deficiency is Associated with microRNA Deregulation in Skeletal Muscle and Plasma

microRNAs (miRNAs) are widespread regulators of gene expression, but little is known of their potential roles in congenital muscular dystrophy type 1A (MDC1A). MDC1A is a severe form of muscular dystrophy caused by mutations in the gene encoding laminin α2 chain. To gain insight into the pathophysio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holmberg, Johan, Alajbegovic, Azra, Gawlik, Kinga Izabela, Elowsson, Linda, Durbeej, Madeleine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080261/ https://www.ncbi.nlm.nih.gov/pubmed/25071564 http://dx.doi.org/10.3389/fnagi.2014.00155

Ejemplares similares

Distinct Roles for Laminin Globular Domains in Laminin α1 Chain Mediated Rescue of Murine Laminin α2 Chain Deficiency
por: Gawlik, Kinga I., et al.
Publicado: (2010)

Deletion of integrin α7 subunit does not aggravate the phenotype of laminin α2 chain-deficient mice
por: Gawlik, Kinga I., et al.
Publicado: (2015)

A Family of Laminin α2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD
por: Gawlik, Kinga I., et al.
Publicado: (2020)

Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies
por: Gawlik, Kinga I, et al.
Publicado: (2011)

Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy
por: Gawlik, Kinga I., et al.
Publicado: (2017)

Early skeletal muscle pathology and disease progress in the dy(3K)/dy(3K) mouse model of congenital muscular dystrophy with laminin α2 chain-deficiency
por: Gawlik, Kinga I., et al.
Publicado: (2019)

Exploratory Profiling of Urine MicroRNAs in the dy(2J)/dy(2J) Mouse Model of LAMA2-CMD: Relation to Disease Progression
por: Moreira Soares Oliveira, Bernardo, et al.
Publicado: (2018)

Bortezomib Does Not Reduce Muscular Dystrophy in the dy(2J)/dy(2J) Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy
por: Körner, Zandra, et al.
Publicado: (2016)

Molecular Regulation of Arterial Aneurysms: Role of Actin Dynamics and microRNAs in Vascular Smooth Muscle
por: Alajbegovic, Azra, et al.
Publicado: (2017)

Antioxidants Reduce Muscular Dystrophy in the dy(2J)/dy(2J) Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy
por: Harandi, Vahid M., et al.
Publicado: (2020)

Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD
por: Moreira Soares Oliveira, Bernardo, et al.
Publicado: (2017)

Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy
por: Nguyen, Quynh, et al.
Publicado: (2019)

Transcription factor GATA6 promotes migration of human coronary artery smooth muscle cells in vitro
por: Alajbegovic, Azra, et al.
Publicado: (2022)

Inducible Deletion of YAP and TAZ in Adult Mouse Smooth Muscle Causes Rapid and Lethal Colonic Pseudo-Obstruction
por: Daoud, Fatima, et al.
Publicado: (2020)

Characterization and Expression of the Laminin γ3 Chain: A Novel, Non-Basement Membrane–associated, Laminin Chain
por: Koch, Manuel, et al.
Publicado: (1999)

Deregulation of Plasma microRNA Expression in a TARDBP-ALS Family
por: Ruffo, Paola, et al.
Publicado: (2023)

YAP and TAZ in Vascular Smooth Muscle Confer Protection Against Hypertensive Vasculopathy
por: Daoud, Fatima, et al.
Publicado: (2022)

Roles for Laminin in Embryogenesis: Exencephaly, Syndactyly, and Placentopathy in Mice Lacking the Laminin α5 Chain
por: Miner, Jeffrey H., et al.
Publicado: (1998)

Native chick laminin-4 containing the beta 2 chain (s-laminin) promotes motor axon growth
Publicado: (1996)

Identification of Candidate Protein Markers in Skeletal Muscle of Laminin-211-Deficient CMD Type 1A-Patients
por: Kölbel, Heike, et al.
Publicado: (2019)

Small-RNA sequencing identifies dynamic microRNA deregulation during skeletal muscle lineage progression
por: Castel, David, et al.
Publicado: (2018)

Immobilization of Dystrophin and Laminin α2-Chain Deficient Zebrafish Larvae In Vivo Prevents the Development of Muscular Dystrophy
por: Li, Mei, et al.
Publicado: (2015)

Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation
Publicado: (1996)

Laminin chain assembly is regulated by specific coiled-coil interactions
por: Macdonald, Philip R., et al.
Publicado: (2010)

microRNA deregulation in Hutchinson-Gilford Progeria
por: Roll, Patrice
Publicado: (2015)

Linker molecules between laminins and dystroglycan ameliorate laminin-α2–deficient muscular dystrophy at all disease stages
por: Meinen, Sarina, et al.
Publicado: (2007)

Interferon Treatment of Multiple Sclerosis
por: Alajbegovic, Azra, et al.
Publicado: (2012)

Post Stroke Depression
por: Alajbegovic, Azra, et al.
Publicado: (2014)

NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species
por: Ghosh, Rajeshwary, et al.
Publicado: (2015)

Uncoordinated production of Laminin-5 chains in airways epithelium of allergic asthmatics
por: Amin, Kawa, et al.
Publicado: (2005)

Histochemical Analysis of Laminin α Chains in Diethylstilbestrol-Induced Prolactinoma in Rats
por: Ramadhani, Dini, et al.
Publicado: (2015)

Changes in Laminin Chain Expression in Pre- and Postnatal Rat Pituitary Gland
por: Ramadhani, Dini, et al.
Publicado: (2014)

The Short Arm of the Laminin γ2 Chain Plays a Pivotal Role in the Incorporation of Laminin 5 into the Extracellular Matrix and in Cell Adhesion
por: Gagnoux-Palacios, Laurent, et al.
Publicado: (2001)

Increased Neointimal Thickening in Dystrophin-Deficient mdx Mice
por: Rauch, Uwe, et al.
Publicado: (2012)

Laminin-221-derived recombinant fragment facilitates isolation of cultured skeletal myoblasts
por: Kihara, Yuki, et al.
Publicado: (2022)

MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma
por: Chen, H-C, et al.
Publicado: (2009)

The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma
por: Özata, Deniz M, et al.
Publicado: (2011)

Deregulated MicroRNAs in Myotonic Dystrophy Type 2
por: Greco, Simona, et al.
Publicado: (2012)

MicroRNA Deregulation in Anaplastic Thyroid Cancer Biology
por: Fuziwara, Cesar Seigi, et al.
Publicado: (2014)

Prognostic significance of deregulated microRNAs in uveal melanomas
por: Falzone, Luca, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sejgove9nngmo11vp2t5ta5f1p